Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Zev Wainberg, MD, considers regorafenib in locally advanced biliary tract cancer

Dr. Wainberg, Co-Director, UCLA Gastro-Intestinal Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology Oncology, David Geffen School of Medicine at UCLA, considers the Phase 2 REACHIN study investigating regorafenib in locally advanced biliary tract cancer

Tags: ASCO GI Conference CoverageLiver (includes HCC, Billiary Tract)

Published: 04 February 2019

Recent Videos

video

Constantine Tam, MD, & Robert Figlin, MD, discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20

Constantine Tam, MD, of Peter MacCallum Cancer Centre and Robert Figlin, MD, of Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai ...

video

Tanios Bekaii-Saab, MD, FACP, considers the emerging role of immunotherapy in advanced CRC treatment

Dr. Bekaii-Saab, Professor of Gastrointestinal Cancer, Mayo Clinic, considers the emerging role of immunotherapy in the treatment of advanced colorectal ...

video

Tanios Bekaii-Saab, MD, FACP, discusses oral chemotherapy in adjuvant and advanced CRC treatment during the COVID era

Dr. Bekaii-Saab, Professor of Gastrointestinal Cancer, Mayo Clinic, discusses oral chemotherapy in the treatment of adjuvant and advanced colorectal cancer ...

video

Thierry Andre, MD, on evolution of I-O towards the first line treatment of colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, discusses the evolution of I-O towards the first line treatment in colorectal ...

video

Thierry Andre, MD, provides thoughts on how to identify patients with CRC unlikely to respond to I-O

Dr. Andre, Professor of Medical Oncology, Sorbonne University, provides thoughts on how to identify patients with colorectal cancer that are ...

video

Thierry Andre, MD, shares design of the Keynote-177 study in metastatic colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, shares the design of the Keynote-177 study investigating the use of pembrolizumab ...

video

Thierry Andre, MD, regarding the outcomes of the Keynote-177 study in metastatic colorectal cancer

Dr. Andre, Professor of Medical Oncology, Sorbonne University, regarding the outcomes of the Keynote-177 study investigating the use of pembrolizumab ...

video

Matthew Galsky, MD, discusses how to identify patients that will likely be good responders for I-O

Dr. Galsky, Professor of Medicine, Mount Sinai School of Medicine, discusses how to identify patients that will likely be good ...

video

Matthew Galsky, MD, considers a new standard of maintenance with the Javelin study outcomes

Dr. Galsky, Professor of Medicine, Mount Sinai School of Medicine, considers whether the outcomes of the Javelin Bladder 100 study ...

video

Matthew Galsky, MD, shares the design and outcomes of the Javelin Bladder 100 study

Dr. Galsky, Professor of Medicine, Mount Sinai School of Medicine, shares the design and outcomes of the Javelin Bladder 100 ...

Related Videos

video-image

Tanios Bekaii-Saab, MD, FACP, discusses oral chemotherapy in adjuvant and advanced CRC treatment during the COVID era

video-image

Tanios Bekaii-Saab, MD, FACP, considers the emerging role of immunotherapy in advanced CRC treatment

video-image

Constantine Tam, MD, & Robert Figlin, MD, discuss progress in Waldenstrom’s Macroglobulinemia & ASCO20

video-image

Matthew Galsky, MD, considers a new standard of maintenance with the Javelin study outcomes

video-image

Matthew Galsky, MD, discusses how to identify patients that will likely be good responders for I-O

video-image

Thierry Andre, MD, regarding the outcomes of the Keynote-177 study in metastatic colorectal cancer

video-image

Thierry Andre, MD, shares design of the Keynote-177 study in metastatic colorectal cancer

video-image

Xiuning Le, MD, PhD, discusses goals and results of the VISION study in non-small cell lung cancer

video-image

Thierry Andre, MD, provides thoughts on how to identify patients with CRC unlikely to respond to I-O

video-image

Roy Herbst, MD, PhD, shares perspective on the plenary session presentation of the ADAURA study

video-image

Thierry Andre, MD, on evolution of I-O towards the first line treatment of colorectal cancer

video-image

Shaji Kumar, MD, shares results of the Phase 3 study regarding 1st line multiple myeloma treatment

video-image

Bruce Feinberg, DO, on the understanding medical oncologists have on social determinants of health

video-image

Matthew Galsky, MD, tells us about the Phase 3 IMvigor130 study in advanced urothelial cancer

video-image

Matthew Galsky, MD, explains which biomarkers likely have the most predictive value

video-image

Matthew Galsky, MD, shares the design and outcomes of the Javelin Bladder 100 study

video-image

Howard Hochster, MD, on identifying patients that are MSI-H and unlikely to respond to pembrolizumab

video-image

Jorge Cortes, MD, tells us about the OPTIC study, a phase 2 investigation of ponatinib in CML

video-image

Howard Hochster, MD, discusses evolution of I-O toward first line treatment of colorectal cancer

video-image

Jorge Cortes, MD, provides thoughts on what the impact of the OPTIC study will be on CML patients